U.S. flag An official website of the United States government
  1. Home
  2. Animal & Veterinary
  3. Products
  4. Animal Food & Feeds
  5. Medicated Feeds
  6. Blue Bird Labels
  7. Cattle
  1. Medicated Feeds

Cattle

Cattle

Beef Cattle (Feedlot)
Calves
Cattle (Multiple Classes)
Dairy Cattle
Growing Cattle
Reproducing Beef Cattle

Marketing Status The following guide explains the marketing status categories used in the tables below:

  • OTC - Product is in over-the-counter marketing status and is not impacted by Guidance for Industry #213 (GFI #213)
  • VFD - Product is in Veterinary Feed Directive Status.

Beef Cattle (Feedlot)

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Bacitracin Methylene Disalicylate PENNITRACIN N141-137 Type B For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. OTC
Bacitracin Methylene Disalicylate PENNITRACIN N141-137 Type C For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. OTC
Bacitracin Methylene Disalicylate PENNITRACIN N141-137 Type B For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. OTC
Bacitracin Methylene Disalicylate PENNITRACIN N141-137 Type C For reduction in the number of liver condemnations due to abscesses in beef steers and heifers fed in confinement for slaughter. OTC
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type B For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. OTC
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type C For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. OTC
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type B For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. OTC
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type C For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle. OTC
Chlortetracycline CHLORMAX N046-699 Type C For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. VFD (Effective 1/1/17)
Chlortetracycline CHLORMAX N046-699 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline CHLORMAX N046-699 Type C For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For beef cattle (over 700 lb) for control of active infection of anaplasmosis caused by A. marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For beef cattle (under 700 lb) for control of active infection of anaplasmosis caused by A. marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For beef cattle control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale
susceptible to chlortetracycline in beef cattle over 700 lbs.
VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For an increased rate of weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses in growing cattle over 400 lbs.  For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B For beef cattle weighing over 700 lb: Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C For beef cattle weighing over 700 lb: Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lb VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lb VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 lbs and for the control of bacterial pneumonia associated with shipping fever complex by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle over 700 lbs. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B  For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B  For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B  For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B  For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by
P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers).
VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type B For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid AUREOMYCIN 100 PLUS N141-250 Type C For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For the control of coccidiosis caused by Eimeria bovis and Eimeria zuemii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For improved feed efficiency and for the treatment of bacterial enteritis caused by E.coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For Improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type B For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuemii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle over 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers). VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline, Lasalocid DERACIN PLUS BOVATEC A200-617 Type C For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in beef cattle under 700 pounds. VFD (Effective 1/1/17)
Decoquinate, Monensin sodium, Tylosin DECCOX, RUMENSIN, TYLAN N141-149 Type B For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Decoquinate, Monensin sodium, Tylosin DECCOX, RUMENSIN, TYLAN N141-149 Type C For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for improved feed efficiency, and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Decoquinate, Monensin sodium, Tylosin phosphate DECCOX, RUMENSIN, TYLOVET 100 A200-533 Type B For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii. for improved feed efficiency, and far reduction in the incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces pyogenes in growing-finishing cattle being fed in confinement for slaughter. VFD (Effective 1/1/17)
Decoquinate, Monensin sodium, Tylosin phosphate DECCOX, RUMENSIN, TYLOVET 100 A200-533 Type C For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii. for improved feed efficiency, and far reduction in the incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces pyogenes in growing-finishing cattle being fed in confinement for slaughter. VFD (Effective 1/1/17)
Laidlomycin propionate potassium CATTLYST N141-025 Type B For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Laidlomycin propionate potassium CATTLYST N141-025 Type B For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Laidlomycin propionate potassium CATTLYST N141-025 Type B For improved feed efficiency in cattle fed in confinement for slaughter. OTC
Laidlomycin propionate potassium CATTLYST N141-025 Type B For improved feed efficiency in cattle fed in confinement for slaughter. OTC
Laidlomycin propionate potassium CATTLYST N141-025 Type C For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Laidlomycin propionate potassium CATTLYST N141-025 Type C For improved feed efficiency in cattle fed in confinement for slaughter. OTC
Lasalocid MGA, BOVATEC, TYLOVET 100 A200-535 Type C For improved feed efficiency and increased rate of weight gain in beef cattle in confinement for slaughter. As of 1/1/17, this use is no longer approved
Lasalocid BOVATEC N096-298 Type B For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Lasalocid BOVATEC N096-298 Type C For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Lasalocid BOVATEC N096-298 Type B For improved feed efficiency in cattle fed in confinement for slaughter OTC
Lasalocid BOVATEC N096-298 Type C For improved feed efficiency in cattle fed in confinement for slaughter OTC
Lasalocid (Liquid) BOVATEC N096-298 Type B For improved feed efficiency in cattle fed in confinement for slaughter OTC
Lasalocid (Liquid) BOVATEC N096-298 Type B For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. OTC
Lubabegron EXPERIOR N141-508 Type B For reduction of ammonia gas emissions per pound of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. OTC
Lubabegron EXPERIOR N141-508 Type C For reduction of ammonia gas emissions per pound of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. OTC
Lubabegron, Monensin, Tylosin Experior, Rumensin, Tylan N141-512 Type C For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. VFD
Lubabegron, Monensin, Tylosin Experior, Rumensin, Tylan N141-512 Type C For reduction of ammonia gas emissions per pound of live weight and hot carcass weight, improved feed efficiency, and reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. VFD
Lubabegron, Monensin Experior, Rumensin N141-514 Type C For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and improved feed efficiency in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. OTC
Lubabegron, Monensin Experior, Rumensin N141-514 Type C For reduction of ammonia gas emissions per pound of live weight and hot carcass weight and prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. OTC
Melengestrol acetate MGA N039-402 Type B (liquid) Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
Heifers Intended for Reproduction: For Suppression of Estrus (Heat).
OTC
Melengestrol acetate MGA N039-402 Type C (liquid) Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
Heifers Intended for Reproduction: For Suppression of Estrus (Heat).
OTC
Melengestrol acetate MGA N039-402 Type B Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
Heifers Intended for Reproduction: For Suppression of Estrus (Heat).
OTC
Melengestrol acetate MGA N039-402 Type C Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
Heifers Intended for Reproduction: For Suppression of Estrus (Heat).
OTC
Zilpaterol

+

Melengestrol acetate or Melengestrol acetate (liquid)
ZILMAX, MGA N141-284 Type C (component feeding) Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
OTC
Zilpaterol
+

Melengestrol acetate or Melengestrol acetate (liquid)
ZILMAX, MGA N141-284 Type C (complete feed) For increased rate of weight gain, improved feed efficiency, increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
OTC
Melengestrol, Ractopamine, Monensin, Tylosin MGA, OPTAFLEXX, RUMENSIN, TYLAN N141-233 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
MelengestrolRactopamine, Monensin, Tylosin (Liquid) MGA, OPTAFLEXX, RUMENSIN, TYLAN N141-233 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin MGA, OPTAFLEXX, RUMENSIN, TYLAN N141-233 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN A200-424 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN A200-424 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin HEIFERMAX, OPTAFLEXX, RUMENSIN, TYLAN A200-424 Type C For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Melengestrol (Liquid), Ractopamine, Monensin, Tylosin ACTOGAIN, RUMENSIN, TYLAN, MGA A200-562 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin ACTOGAIN, RUMENSIN, TYLAN, MGA A200-562 Type C Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat). VFD (Effective 1/1/17)
Melengestrol, Ractopamine, Monensin, Tylosin ACTOGAIN, RUMENSIN, TYLAN, MGA A200-562 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Melengestrol, Lasalocid, Tylosin HEIFERMAX, BOVATEC, TYLAN A200-430 Type C For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers being fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol, Lasalocid, Tylosin HEIFERMAX, BOVATEC, TYLAN A200-430 Type C For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol + Lasalocid and Tylosin MGA, BOVATEC, TYLOVET A200-535 Type C For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers being fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol, Lasalocid, Tylosin MGA, BOVATEC, TYLOVET A200-535 Type C For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol, Tylosin (Liquid) MGA, TYLAN N138-995 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Melengestrol, Tylosin MGA, TYLAN N138-995 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Melengestrol, Tylosin HEIFERMAX, TYLAN A200-427 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Melengestrol, Tylosin HEIFERMAX, TYLAN A200-427 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Melengestrol, Monensin, Tylosin HEIFERMAX, RUMENSIN, TYLAN A200-375 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol, Monensin, Tylosin HEIFERMAX, RUMENSIN, TYLAN A200-375 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin RUMENSIN N095-735 Type B For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, improved feed efficiency. OTC
Monensin RUMENSIN N095-735 Type C For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii. OTC
Monensin RUMENSIN N095-735 Type C For improved feed efficiency. OTC
Monensin (Liquid) RUMENSIN N095-735 Type B For improved feed efficiency. OTC
Monensin and Tylosin Phosphate (Liquid) RUMENSIN AND TYLAN N104-646 Type B For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate RUMENSIN AND TYLAN N104-646 Type B For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate RUMENSIN AND TYLAN N104-646 Type C For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate RUMENSIN AND TYLAN N104-646 Type C For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate RUMENSIN AND TYLAN N104-646 Type B For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes... VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate (Liquid) RUMENSIN AND TYLAN N104-646 Type B For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes... VFD (Effective 1/1/17)
Monensin and Tylosin Phosphate (Liquid) RUMENSIN AND TYLOVET 100 A200-531 Type B For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necropliorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin and Tylosin (Liquid) RUMENSIN AND TYLOVET 100 A200-531 Type B For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin and Tylosin RUMENSIN AND TYLOVET 100 A200-531 Type B For prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobactenum (Actinomyces) pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin and Tylosin RUMENSIN AND TYLOVET 100 A200-531 Type B For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin and Tylosin RUMENSIN AND TYLOVET 100 A200-531 Type C For prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter VFD (Effective 1/1/17)
Monensin and Tylosin RUMENSIN AND TYLOVET 100 A200-531 Type C For improved feed efficiency and reduction of incidence of liver abscesses caused by Fusobactenum necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Ractopamine (top-dress)

+

Monensin and Tylosin
RUMENSIN, TYLOVET 100, ACTOGAIN 45 A200-585 Type C Actogain: For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine OPTAFLEXX 45 N141-221 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness... OTC
Ractopamine OPTAFLEXX 45 N141-221 Type B For increased rate of weight gain and improved feed efficiency... OTC
Ractopamine OPTAFLEXX 45 N141-221 Type C For increased rate of weight gain and improved feed efficiency... OTC
Ractopamine OPTAFLEXX 45 N141-221 Type C For increased rate of weight gain, improved feed efficiency, and increased carcass leanness... OTC
Ractopamine OPTAFLEXX 45 N141-221 Type C For increased rate of weight gain and improved feed efficiency... OTC
Ractopamine (Liquid) OPTAFLEXX 45 N141-221 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness... OTC
Ractopamine (Liquid) OPTAFLEXX 45 N141-221 Type B For increased rate of weight gain and improved feed efficiency... OTC
Ractopamine (Liquid for Top-Dress) ACTOGAIN 45 A200-548 Type B For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine ACTOGAIN 45 A200-548 Type B For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine ACTOGAIN 45 A200-548 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine (Liquid) ACTOGAIN 45 A200-548 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine ACTOGAIN 45 A200-548 Type B For increased rate of weight gain and improved feed efficiency, and for increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine ACTOGAIN 45 A200-548 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine ACTOGAIN 45 A200-548 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. OTC
Ractopamine and Monensin Plus OPTAFLEXX AND RUMENSIN N141-225 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness, and control of coccidiosis due to Eimeria bovis and E. zuernii... OTC
Ractopamine and Monensin Plus OPTAFLEXX AND RUMENSIN N141-225 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness, and control of coccidiosis due to Eimeria bovis and E. zuernii... OTC
Ractopamine and Monensin OPTAFLEXX AND RUMENSIN N141-225 Type C For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... OTC
Ractopamine and Monensin OPTAFLEXX AND RUMENSIN N141-225 Type B For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... OTC
Ractopamine and Monensin (Liquid) OPTAFLEXX AND RUMENSIN N141-225 Type B For increased rate of weight gain, improved feed efficiency, and control of coccidiosis due to Eimeria bovis and E. zuernii... OTC
Ractopamine and Monensin

+

Melengestrol Acetate or Melengestrol Acetate (Liquid)
HEIFERMAX, RUMENSIN AND RACTOPAMINE A200-448 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii...

Heifermax: For Beef and Dairy Heifers...For increased weight gain, improved feed efficiency, and suppression of estrus (heat).
OTC
Ractopamine and Monensin

+

Melengestrol acetate
Actogain 45, Rumensin, MGA A200-560 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter during the last 28 to 42 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For lncreased Rate of Weight Gain, lmproved Feed
Efficiency and Suppression of Estrus (Heat).
OTC
Ractopamine, Monensin, Tylosin OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin, Tylosin OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin, Tylosin OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin, Tylosin (liquid) OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin, Tylosin OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin, Tylosin OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type C For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine,

+ Monensin, Tylosin
OPTAFLEXX, RUMENSIN, TYLOVET A200-566 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Melengestrol acetate or Liquid Melengestrol acetate

+ Monensin and Tylosin
ACTOGAIN 45, RUMENSIN, TYLOVET 100, MGA A200-583 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin (Liquid) OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin (Liquid) OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type C For increased rate of weight gain, improved feed efficiency, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin OPTAFLEXX, RUMENSIN AND TYLAN N141-224 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type B (liquid) For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type B (liquid) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine hydrochloride

+

Monensin and Tylosin
ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type C (top-dress) For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type C For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLAN A200-561 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type B For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin Plus ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type B (carcass leanness) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type B (liquid) For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type C For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Ractopamine, Monensin and Tylosin Plus ACTOGAIN 45, RUMENSIN, TYLOVET 100 A200-585 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed. VFD (Effective 1/1/17)
Tilmicosin and Monensin RUMENSIN AND PULMOTIL N141-343 Type B For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin RUMENSIN AND PULMOTIL N141-343 Type C For prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin RUMENSIN AND PULMOTIL N141-343 Type B For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin RUMENSIN AND PULMOTIL N141-343 Type C For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin TILMOVET AND RUMENSIN A200-596 Type B For prevention and control of coccidlosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin TILMOVET AND RUMENSIN A200-596 Type B For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin TILMOVET AND RUMENSIN A200-596 Type C For prevention and control of coccidlosis due to Eimeria bovis and Eimeria zuernii and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin and Monensin TILMOVET AND RUMENSIN A200-596 Type C For improved feed efficiency and control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of cattle fed in confinement for slaughter, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type B (component) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type C (component) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type B (liquid) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN AND TYLAN N141-276 Type B (liquid - component feeding) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin (liquid) ZILMAX, RUMENSIN, TYLOVET A200-547 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN, TYLOVET A200-547 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin ZILMAX, RUMENSIN, TYLOVET A200-547 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii, and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. VFD (Effective 1/1/17)
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type B (liquid - component feeding) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type B (component feeding) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type B (liquid) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type C (component) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin ZILMAX AND RUMENSIN N141-278 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed. OTC
Zilpaterol ZILMAX N141-258 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... OTC
Zilpaterol ZILMAX N141-258 Type B (component) For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. OTC
Zilpaterol (Liquid) ZILMAX N141-258 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... OTC
Zilpaterol (Liquid) ZILMAX N141-258 Type B (component) For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. OTC
Zilpaterol ZILMAX N141-258 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter... OTC
Zilpaterol ZILMAX N141-258 Type C (component) For increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. OTC
Zilpaterol, Monensin, Tylosin (complete feed)

Melengestrol acetate (complete feed), Melengestrol acetate (liquid complete feed)
ZILMAX, RUMENSIN, TYLAN AND MGA N141-280 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
VFD (Effective 1/1/17)
Zilpaterol, Monensin, Tylosin (component feed)

+ Melengestrol acetate (component feed),  Melengestrol acetate (liquid component feed)
ZILMAX, RUMENSIN, TYLAN AND MGA N141-280 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuemii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
VFD (Effective 1/1/17)
Zilpaterol, Monensin

+

Melengestrol acetate or Liquid Melengestrol acetate
ZILMAX, RUMENSIN AND MGA N141-282 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
OTC
Zilpaterol, Monensin

+

Melengestrol acetate or Liquid Melengestrol acetate
ZILMAX, RUMENSIN AND MGA N141-282 Type C (component feeding) For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis due to Eimeria bovis and E. zuernii in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

MGA:

MGA: Heifers Fed in Confinement for Slaughter: For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
OTC
Zilpaterol, Monensin, Tylosin

+

Melengestrol Acetate or Melengestrol Acetate (Liquid)
ZILMAX, RUMENSIN, TYLOVET 100 AND MGA A200-544 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

Heifermax: Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
VFD (Effective 1/1/17)

Back to the top

Calves

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Amprolium AMPROL N012-350 Type B An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zurnii in calves.  OTC
Amprolium AMPROL N012-350 Type C An aid in the prevention and treatment of coccidiosis caused by Eimeria bovis and E. zurnii in calves. OTC
Chlortetracycline CHLORMAX N046-699 Type C For an increased rate of weight gain and improved feed efficiency in calves between 250 and 400 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline CHLORMAX N046-699 Type C For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type B For an increased rate of weight gain and improved feed efficiency in calves 250 to 400 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type C For an increased rate of weight gain and improved feed efficiency in calves 250 to 400 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type B For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type C For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline CLTC N092-287 Type C (milk replacer) For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-287 Type C (hand-fed) For calves (up to 250 lb) for the treatment of bacterial enteritis caused by E. coli susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-287 Type C (milk replacer) For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Chlortetracycline CLTC N092-287 Type C For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Chlortetracycline CLTC N092-287 Type C For calves (up to 250-400 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Chlortetracycline DERACIN A200-510 Type B For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline DERACIN A200-510 Type C For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline DERACIN A200-510 Type B For an increased rate of weight gain and improved feed efficiency in calves 250 to 400 lbs. As of 1/1/17, this use is no longer approved
Chlortetracycline DERACIN A200-510 Type C For an increased rate of weight gain and improved feed efficiency in calves 250 to 400 lbs. As of 1/1/17, this use is no longer approved
Lasalocid BOVATEC N096-298 Type C For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in replacement calves OTC
Monensin RUMENSIN N095-735 Type C For calves (excluding veal calves): the prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. OTC
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B For calves (up to 250 lb) for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C For calves (up to 250 lb) for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B For calves (up to 250 Ib) for increased rate of weight gain and improved feed efficiency As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C For calves (up to 250 Ib) for increased rate of weight gain and improved feed efficiency As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type B For increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type B For use in manufacturing medicated calf feed for use in calf milk replacers or starter feeds. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For increased rate of weight gain and improved feed efficiency in calves up to 250 lbs for use in calf starter feeds. As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For increased rate of weight gain and improved feed efficiency in calves up to 250 lbs for use in calf milk replacers. As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin in calves up to 250 lbs for use in milk replacers or starter feeds. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For increased rate of weight gain and improved feed efficiency in calves 250-400 lbs. As of 1/1/17, this use is no longer approved
Oxytetracycline TERRAMYCIN N008-804 Type B For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. VFD-12/7/16
Oxytetracycline TERRAMYCIN N008-804 Type C For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. VFD-12/7/16
Oxytetracycline OXTC N095-143 Type B For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type C For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type C (milk replacer) For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type B For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For calves for treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OTC N138-938 Type B For use in manufacturing medicated cattle feed. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline in calves for use in calf milk replacers or starter feeds. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs. As of 1/1/17, this use is no longer approved
Oxytetracycline OTC N138-938 Type C For an increased rate of weight gain and improved feed efficiency in calves up to 250 lbs for use in calf milk replacers or starter feeds. As of 1/1/17, this use is no longer approved
Oxytetracycline OTC N138-938 Type C For an increased rate of weight gain, and improved feed efficiency in calves weighing 250 - 400 lbs. As of 1/1/17, this use is no longer approved

Back to the top

Cattle (Multiple Classes)

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Bambermycins (Liquid) GAINPRO N141-034 Type B For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter. OTC
Bambermycins GAINPRO N141-034 Type B For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy and beef replacement heifers). OTC
Bambermycins GAINPRO N141-034 Type C For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter. OTC
Bambermycins GAINPRO N141-034 Type C For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy
and beef replacement heifers).
OTC
Bambermycins GAINPRO N141-034 Type C For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy
and beef replacement heifers).
OTC
Chlortetracycline CHLORMAX N046-699 Type C Calves, beef, and non-lactating dairy cattle: For treatment of bacterial enteritis caused by Escherichia coli and for bacterial pneumonia caused by Pasteurella multocida organisms. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For beef and non-lactating dairy cattle: as an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B Calves, Beef and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to Chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C Calves, Beef and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to Chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For calves, beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type B For use in manufacturing medicated cattle feed. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline in calves, beef and non-lactating dairy cattle. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C - top-dress For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chloretracycline DERACIN A200-510 Type C For calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C - free-choice mineral For beef and non-lactating dairy cattle: as an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type B For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type B For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type B For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency in beef cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type C For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in beef cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type C For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type C For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp.-susceptible to chlortetracycline, and for improved feed efficiency in beef cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN, CATTLYST N141-201 Type C For the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Laidlomycin propionate potassium AUREOMYCIN N141-201 Type B For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline, and for improved feed efficiency and increased rate of weight gain in beef cattle fed in confinement for slaughter. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine AUREO S N035-805 Type B As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine AUREO S N035-805 Type C As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine PENNCHLOR S A200-314 Type B As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine PENNCHLOR S A200-314 Type C As an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever. VFD (Effective 1/1/17)
Decoquinate DECCOX N039-417 Type B For the prevention of coccidiosis in cattle (including ruminating and non-ruminating calves and veal calves) caused by Eimeria bovis and E. zuernii. OTC
Decoquinate (liquid) DECCOX N039-417 Type B For the prevention of coccidiosis in cattle (including ruminating and non-ruminating calves and veal calves) caused by Eimeria bovis and E. zuernii. OTC
Decoquinate and Chlortetracycline DECCOX, DERACIN A200-622 Type B Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline DECCOX, DERACIN A200-622 Type C Calves, beef, and non-lactating dairy cattle: For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline DECCOX, DERACIN A200-622 Type C Calves, beef, and non-lactating dairy cattle: For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline CHLORMAX, DECCOX N141-147 Type B Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline CHLORMAX, DECCOX N141-147 Type C Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline CHLORMAX, DECCOX N141-147 Type C Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline AEUROMYCIN, DECCOX N141-185 Type B Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline AEUROMYCIN, DECCOX N141-185 Type C (top-dress) Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline AEUROMYCIN, DECCOX N141-185 Type C Calves, beef, and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline PENNCHLOR, DECCOX A200-359 Type B Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline PENNCHLOR, DECCOX A200-359 Type C Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Chlortetracycline PENNCHLOR, DECCOX A200-359 Type C Calves, beef and non-lactating dairy cattle. For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii; for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. VFD (Effective 1/1/17)
Decoquinate and Monensin sodium DECCOX, RUMENSIN N141-148 Type B For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, and improved feed efficiency in cattle being fed in confinement for slaughter. OTC
Decoquinate and Monensin sodium DECCOX, RUMENSIN N141-148 Type C For the prevention of coccidiosis caused by Eimeria bovis and E. zuernii, and improved feed efficiency in cattle being fed in confinement for slaughter. OTC
Fenbendazole SAFE-GUARD N131-675 Type B For the removal and control of: Lungworms: (Dictyocaulus viviparus)  Stomach worms: Barberpole worms (Haemonchus contortus), brown stomach worms (Ostertagia ostertagi), small stomach worms (Trichostrongylus axei)   Intestinal worms: Hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora)  Bankrupt worms: (Trichostrongylus colubriformis)   Nodular worms: (Oesophaogostomum radiatum) OTC
Fenbendazole SAFE-GUARD N131-675 Type C For the removal and control of: Lungworms: (Dictyocaulus viviparus)  Stomach worms: Barberpole worms (Haemonchus contortus), brown stomach worms (Ostertagia ostertagi), small stomach worms (Trichostrongylus axei)   Intestinal worms: Hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora)  Bankrupt worms: (Trichostrongylus colubriformis)   Nodular worms: (Oesophaogostomum radiatum) OTC
Lasalocid BOVATEC N096-298 Type B For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. OTC
Lasalocid BOVATEC N096-298 Type C For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. OTC
Lasalocid BOVATEC N096-298 Type B For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). OTC
Lasalocid BOVATEC N096-298 Type C For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). OTC
Lasalocid (Liquid) BOVATEC N096-298 Type B For control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle up to 800 lbs. OTC
Lasalocid (Liquid) BOVATEC N096-298 Type B For increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). OTC
Melengestrol Acetate, Monensin (Liquid) HEIFERMAX AND RUMENSIN A200-422 Type C For Beef and Dairy Heifers...Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and
prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.
OTC
Melengestrol Acetate, Monensin HEIFERMAX AND RUMENSIN A200-422 Type C For Beef and Dairy Heifers...Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and
prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.
OTC
Melengestrol Acetate, Monensin, Tylosin MGA, RUMENSIN AND TYLAN N138-870 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention
and control of coccidiosis..., reduction of incidence of liver abscesses...
VFD (Effective 1/1/17)
Melengestrol Acetate, Monensin, Tylosin (Liquid) MGA, RUMENSIN AND TYLAN N138-870 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis..., reduction of incidence of liver abscesses... VFD (Effective 1/1/17)
Melengestrol Acetate and Tylosin Phosphate MGA and TYLAN N139-192 Type C For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses ... VFD (Effective 1/1/17)
Melengestrol Acetate and Tylosin Phosphate (Liquid) MGA and TYLAN N139-192 Type C For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses ... VFD (Effective 1/1/17)
Melengestrol Acetate and Tylosin Phosphate (Liquid) MGA AND TYLOVET A200-532 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes VFD (Effective 1/1/17)
Melengestrol Acetate and Tylosin Phosphate MGA AND TYLOVET A200-532 Type C Heifers being fed in confinement for slaughter: For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces (Corynebacterium) pyogenes VFD (Effective 1/1/17)
Melengestrol acetate, Monensin, and Tylosin phosphate (Liquid) MGA, RUMENSIN AND TYLOVET A200-534 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Melengestrol acetate, Monensin, and Tylosin phosphate MGA, RUMENSIN AND TYLOVET A200-534 Type C Increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii, reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter. VFD (Effective 1/1/17)
Monensin RUMENSIN N095-735 Type B For increased rate of weight gain; For prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). OTC
Monensin RUMENSIN N095-735 Type C For increased rate of weight gain; For prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). OTC
Morantel tartrate RUMANTEL N092-444 Type C For the removal and control of mature gastrointestinal nematode infections of cattle including stomach worms (Haemonchus spp., Ostertagia spp., Trichostrongylus spp.), worms of the small intestine (Cooperia spp., Trichostrongylus spp., Nematodirus spp.), and worms of large intestine (Oesophagostomum radiatum). OTC
Ractopamine, Monensin, Tylosin

+

Melengestrol acetate or Liquid Melengestrol acetate
OPTAFLEXX, RUMENSIN, TYLOVET, MGA A200-567 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to Eimeria bovis and E. zuernii and reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes in cattle fed in confinement for slaughter for the last 28 to 42 days on feed.

MGA: Heifers fed in confinement for slaughter: for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat).
VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B For cattle for prevention and treatment of the early stages of shipping fever complex VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C For cattle for prevention and treatment of the early stages of shipping fever complex VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type B For use in manufacturing medicated cattle feed. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin in calves, beef and non-lactating dairy cattle. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For prevention and treatment of the early stages of shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type B For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type C For calves and beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type B For calves, beef cattle and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type C For calves, beef cattle, and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type B For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For growing cattle (over 400 lb) for reduction of liver condemnation due to liver abscesses. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type B For calves, beef cattle and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For calves, beef cattle, and nonlactating dairy cattle for prevention and treatment of the early stages of shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type B For calves and beef and non-lactating dairy cattle for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For calves and beef and nonlactating dairy cattle, for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type B For use in manufacturing medicated calf feed for use in calf milk replacers or starter feeds. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For the prevention and treatment of the early stages of the shipping fever complex. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida organisms susceptible to oxytetracycline in calves, beef and non-lactating dairy cattle. VFD (Effective 1/1/17)
Poloxalene BLOAT GUARD N032-704 Type C For prevention of legume (alfalfa, clover) and wheat pasture bloat in cattle. OTC
Poloxalene BLOAT GUARD N038-281 Type C For control of legume (alfalfa, clover) and wheat pasture bloat in cattle. OTC
Poloxalene BLOAT GUARD N038-281 Type C For control of legume (alfalfa, clover) and wheat pasture bloat in cattle. OTC
Tilmicosin PULMOTIL N141-064 Type B For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin PULMOTIL N141-064 Type C For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin TILMOVET A200-509 Type B For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group. VFD
Tilmicosin TILMOVET A200-509 Type C For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group.  VFD
Tylosin (Liquid) TYLAN N012-491 Type B For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type B For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Tylosin phosphate TYLOVET A200-484 Type C For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Tylosin phosphate TYLOVET A200-484 Type B For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Tylosin phosphate (liquid) TYLOVET A200-484 Type B For reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Arcanobacterium (Actinomyces) pyogenes. VFD (Effective 1/1/17)
Tylosin phosphate, Melengestrol acetate TYLOVET A200-484 Type C For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes. VFD (Effective 1/1/17)
Virginiamycin V-MAX N140-998 Type B For improved feed efficiency As of 1/1/17, this use is no longer approved.
Virginiamycin V-MAX N140-998 Type C For improved feed efficiency. As of 1/1/17, this use is no longer approved.
Virginiamycin V-MAX N140-998 Type B For increased rate of weight gain As of 1/1/17, this use is no longer approved.
Virginiamycin V-MAX N140-998 Type C For increased rate of weight gain As of 1/1/17, this use is no longer approved.
Virginiamycin V-MAX N140-998 Type B For reduction of incidence of liver abscesses. VFD (Effective 1/1/17)
Virginiamycin V-MAX N140-998 Type C For reduction of incidence of liver abscesses. VFD (Effective 1/1/17)
Zilpaterol ZILMAX, HEIFERMAX A200-483 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. OTC
Zilpaterol

+

Melengestrol Acetate or Melengestrol Acetate (Liquid)
ZILMAX, HEIFERMAX A200-483 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed.

Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
OTC
Zilpaterol (Liquid) ZILMAX, HEIFERMAX A200-483 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed. OTC
Zilpaterol and Monensin ZILMAX, RUMENSIN A200-479 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis... OTC
Zilpaterol and Monensin (Liquid) ZILMAX, RUMENSIN A200-479 Type B For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis... OTC
Zilpaterol and Monensin

+ Melengestrol Acetate or Melengestrol Acetate (Liquid)
ZILMAX, RUMENSIN, HEIFERMAX A200-479 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, and prevention and control of coccidiosis...

Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
OTC
Zilpaterol, Monensin, and Tylosin Phosphate

+

Melengestrol Acetate or Melengestrol Acetate (Liquid)
ZILMAX, RUMENSIN, TYLAN, AND HEIFERMAX A200-480 Type C For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis ... and reduction of incidence of liver abscesses ... in cattle fed in confinement for slaughter for the last 20 to 40 days on feed.

Heifermax: For Beef and Dairy Heifers...Heifers Fed in Confinement for Slaughter: For Increased Rate of Weight Gain, Improved Feed Efficiency and Suppression of Estrus (Heat).
VFD (Effective 1/1/17)

Back to the top

Dairy Cattle

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Monensin (Liquid) RUMENSIN N095-735 Type B For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). OTC
Monensin RUMENSIN N095-735 Type B For increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). OTC
Monensin RUMENSIN N095-735 Type C For total mixed rations: increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). OTC
Monensin RUMENSIN N095-735 Type C For component feeding systems (including top dress): increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake). OTC

Back to the top

Growing Cattle

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Bacitracin Zinc ALBAC A200-223 Type B For an increased rate of weight gain and improved feed efficiency. OTC
Bacitracin Zinc ALBAC A200-223 Type C For an increased rate of weight gain and improved feed efficiency. OTC
Chlortetracycline CHLORMAX N046-699 Type C For the reduction of the incidence of liver abscesses VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B For the reduction of the incidence of liver abscesses VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C For the reduction of the incidence of liver abscesses VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For growing cattle (over 400 lb) for reduction of the incidence of liver abscesses. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Monensin RUMENSIN N095-735 Type B For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). OTC
Monensin RUMENSIN N095-735 Type C For increased rate of weight gain; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii in growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers). OTC
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type B For growing cattle (over 400 lb) for the reduction of incidence of liver abscesses. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type C For growing cattle (over 400 lb) for the reduction of incidence of liver abscesses. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For the reduction of the incidence of liver abscesses in growing cattle over 400 lbs. VFD (Effective 1/1/17)

Back to the top

Reproducing Beef Cattle

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Monensin RUMENSIN N095-735 Type B For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. OTC
Monensin RUMENSIN N095-735 Type C For mature reproducing beef cows (on pasture or in dry lot): improved feed efficiency when receiving supplemental feed; prevention and control of coccidiosis caused by Eimeria bovis and Eimeria zuernii. OTC

 Back to the top